《大行報告》里昂上調港交所(00388.HK)目標價至687元 評級「買入」
里昂發表報告指,籌備多年後港交所(00388.HK)終推出A股期貨,於10月推出以MSCI中國A50互聯互通指數期貨合約,為港交所打開A股市場的里程碑,料可吸引更多海外投資者,而開通的時機亦屬正面驚喜,相信是內地政府表示並非不歡迎海外資本於中國投資的強烈訊息,相信相關舉措對港交所絕對有利,上調港交所未來兩年盈測3%至4%,料其2022年至2023年來自衍生工具收入可上升24%至30%,目標價相應自665元上調至687元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.